An educational intervention to understand Attitudes and address Barriers to Care in Age-related Macular Degeneration: A randomised controlled trial

Not Applicable

Recruiting

• Conditions: Age-related macular degeneration; Eye - Diseases / disorders of the eye

• Registration Number: ACTRN12622000984796
• Lead Sponsor: niversity of New South Wales

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-07-13
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 130

Inclusion Criteria

Adults (age greater than 50) diagnosed at the Centre for Eye Health between with:
• Large drusen at the macula in either eye,
• Pigmentary abnormalities associated with at least medium sized drusen in either eye,
• Late AMD (geographic atrophy)
• Late AMD (macular neovascularization)

Exclusion Criteria

Potential participants must be able to communicate effectively in English and be legally capable to provide formal written direct consent to participate.
Potential participants intending to move outside of the study catchment area (NSW) over the duration of study conduct will not be eligible.
Patients with other co-morbid ocular disease (Ex. glaucoma) requiring treatment will also not be eligible to participate.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Composite measure of attitudes towards appropriate care for AMD will be assessed with study-specific questionnaires:<br>- attitude towards smoking cessation; <br>- attitude towards antioxidant supplementation; <br>- attitude towards use of the Amsler Grid to monitor progression and;<br>- attitude toward anti-VEGF treatment.[6 months post-enrolment.]